1. Home
  2. List
Reference Patent

Reference - List

  • 12 Hits
  • Search Condition : Filter (MeSH = Small Cell Lung Carcinoma / pathology)
Species Resource Title
Human and Animal Cells A549 Notch1 signaling controls cell proliferation, apoptosis and differentiation in lung carcinoma.
Human and Animal Cells LC-2/ad(RCB0440) HADHA is a potential predictor of response to platinum-based chemotherapy for lung cancer.
Human and Animal Cells MBT-2(RCB0544) Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC.
DNA material pENTR4-H1 (RDB04395) , CS-RfA-CG (RDB04390) CADM1 promotes malignant features of small-cell lung cancer by recruiting 4.1R to the plasma membrane.
Human and Animal Cells Lu-134-A(RCB0466) , Lu-134-B(RCB0467) , Lu-139(RCB0469) An integrative transcriptome analysis reveals a functional role for thyroid transcription factor-1 in small cell lung cancer.
Human and Animal Cells Lu-165(RCB1184) MYCL is a target of a BET bromodomain inhibitor, JQ1, on growth suppression efficacy in small cell lung cancer cells.
Human and Animal Cells PC-9(RCB4455) Class III/IV POU transcription factors expressed in small cell lung cancer cells are involved in proneural/neuroendocrine differentiation.
Human and Animal Cells Long noncoding RNA HOTAIR is relevant to cellular proliferation, invasiveness, and clinical relapse in small-cell lung cancer.
Human and Animal Cells A549(RCB0098) Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system.
Human and Animal Cells Lu-134-A(RCB0466) , Lu-135(RCB0468) , Lu-139(RCB0469) POU domain transcription factor BRN2 is crucial for expression of ASCL1, ND1 and neuroendocrine marker molecules and cell growth in small cell lung cancer.
Human and Animal Cells RERF-LC-AI(RCB0444) Detection of tumor-specific autoantibodies in sera of patients with lung cancer.
Human and Animal Cells MS-1(RCB0725) , Lu-139(RCB0469) Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer.